Clinical Trial Update: Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating metabolic flexibility as a therapeutic approach for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Snippet

Sponsor: The University of Queensland | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Phase 2 | Status: COMPLETED